Development of an Innovative Efonidipine Hydrochloride Ethanoate Co-crystals with Dicarboxylic Acids: In-Vitro, Bioavailability and Antihypertensive Properties
- 12 December 2024
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 19 (6) , 1-15
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The Medical Treatment of Stable Angina2018
- Solid dispersions of efonidipine hydrochloride ethanolate with improved physicochemical and pharmacokinetic properties prepared with microwave treatmentEuropean Journal of Pharmaceutics and Biopharmaceutics, 2016
- Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5Advanced Drug Delivery Reviews, 2016
- Baicalein–Nicotinamide Cocrystal with Enhanced Solubility, Dissolution, and Oral BioavailabilityJournal of Pharmaceutical Sciences, 2014
- Coformer Screening Using Thermal Analysis Based on Binary Phase DiagramsPharmaceutical Research, 2014
- Preparation, Characterization, and Evaluation of Dipfluzine–Benzoic Acid Co-crystals with Improved Physicochemical PropertiesPharmaceutical Research, 2013
- Detection of Cocrystal Formation Based on Binary Phase Diagrams Using Thermal AnalysisPharmaceutical Research, 2012
- Improving Mechanical Properties of Crystalline Solids by Cocrystal Formation: New Compressible Forms of ParacetamolAdvanced Materials, 2009
- Studies on the hypotensive mechanisms of NZ-105, a new dihydropyridine derivative, in rats and rabbitsGeneral Pharmacology: The Vascular System, 1993
- On the polymorphism of pharmaceuticals and other molecular crystals. IMicrochimica Acta, 1979